ClinicalTrials.Veeva

Menu

Financial Support in an Underserved and Low-Income Population With Heart Failure (FUND-HF)

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Medication Adherence
Heart Failure, Systolic
Financial Stress
Quality of Life

Treatments

Behavioral: Financial Support

Study type

Interventional

Funder types

Other

Identifiers

NCT05928026
STU-2022-1033

Details and patient eligibility

About

The goal of this clinical trial is to test whether financial support in the form of a one-time $500 stipend would improve medication adherence and quality of life in low-income, socially-needy patients with heart failure with reduced ejection fraction in the post-discharge setting. The main questions it aims to answer are:

  • Will financial support improve heart failure quality of life?
  • Will financial support improve medication adherence?

Participants will complete surveys on quality of life, social stress, and spending habits at their baseline visit. Participants will be randomly assigned to receive $500 at their baseline visit or $0 at their baseline visit. At their one month visit, quality of life and medication adherence will be assessed. These results will be compared between groups. The group that received $0 at their baseline visit will be provided $500 at their one-month visit and return for a two-month visit. At that visit, quality of life and medication adherence will be assessed. These results will be compared to their one-month results.

Researchers will compare the 1-month quality of life scores and medication adherence scores between the immediate financial support vs delayed financial support. Researchers will also compare 1-month vs 2-month quality of life and adherence data for participants who were randomized to the delayed financial support group.

Enrollment

153 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18

  • English speaking participants who completed SOCIAL-HF study surveys

  • Ejection Fraction <=40% and eligible for at least one component of GDMT

  • Has at least some difficulty paying monthly bills (Somewhat Difficult and Very Difficult)

  • Annual household income <130% Federal Poverty Limit

  • Have at least two additional social needs based on the following domains:

    • Cost-related nonadherence
    • Food Insecurity
    • Housing Instability
    • Transportation Difficulty
    • Unemployment
    • Household Crowding: Person/Room Ratio >1
    • Rent Burden: Rent/Income Ratio >30%
    • Low social support
    • Interpersonal Violence
    • History of Discrimination

Exclusion criteria

  • Unwilling to return for 1 and 2-month follow-up visits.
  • Currently in jail or prison
  • Primary residence outside Dallas County
  • Legal Blindness
  • Systolic blood pressure <90 mmHg on screening
  • Contraindications or Intolerance all medications available for therapeutic drug monitoring (metoprolol, losartan, lisinopril, valsartan, and spironolactone)
  • Unable to answer orientation questions.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

153 participants in 2 patient groups

Immediate Financial Support
Experimental group
Description:
This group will receive $500 at the completion of their baseline visit
Treatment:
Behavioral: Financial Support
Delayed Financial Support
Active Comparator group
Description:
This group will receive no financial support at their completion of their baseline visit, but will receive $500 at their 1-month visit.
Treatment:
Behavioral: Financial Support

Trial contacts and locations

1

Loading...

Central trial contact

Ambarish Pandey, MD, MSCS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems